The degradation of ERα could significantly enhance activities by reducing the transcription of genes downstream of ERα and inhibiting the proliferation of ERα-positive breast cancer cells, thus leading to in vivo tumor regression in the MCF-7 mouse xenograft model (Jiang et al., 2018). Here, ESR1 is linked to breast cancer.